Biblio

Found 4 results

Filters: Keyword is Combined Modality Therapy [Clear All Filters]

2025

Kshirsagar RS, Eide JG, Harris J, Abiri A, Beswick DM, Chang EH, Fung N, Hong M, Johnson BJ, Kohanski MA et al.. 2025. Outcomes of Immunotherapy Treatment in Sinonasal Mucosal Melanoma.. Am J Rhinol Allergy. 39(2):102-108.

2020

Xu MJue, Plonowska KA, Gurman ZR, Humphrey AK, Ha PK, Wang SJ, El-Sayed IH, Heaton CM, George JR, Yom SS et al.. 2020. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.. Laryngoscope. 130(2):E48-E56.

2019

Sun L, Chin R-I, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT et al.. 2019. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.. JAMA Dermatol. 155(4):442-447.

2017

Kashat L, Le CH, Chiu AG. 2017. The Role of Targeted Therapy in the Management of Sinonasal Malignancies.. Otolaryngol Clin North Am. 50(2):443-455.